[1]
Stein Gold, L., Gooderham, M., Papp, K., Ferris, L., Lebwohl, M., Adam, D., Alonso-Llamazares, J. , Hong, C.- ho, Kempers, S., Kircik, L. , Jing Loo, W., Stewart, D., Nahm, W., Zirwas, M., Burnett, P., Higham, R., Navale, L. and Berk, D. 2021. Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s44. DOI:https://doi.org/10.25251/skin.5.supp.44.